Ichnos Glenmark Innovation receives upfront payment of $700 million from AbbVie
The payment is in accordance with the agreed contractual terms
The payment is in accordance with the agreed contractual terms
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Subscribe To Our Newsletter & Stay Updated